The Federal Government’s response to the 'Silent Disease' inquiry into hepatitis C in Australia falls well short of what anyone living with hepatitis C could have hoped.
A unique longitudinal real life study on entecavir-treated children and adolescents have found that HBV DNA results at six and twelve months after starting treatment, are predictors of viral suppression.
The Australasian Hepatology Association has released guidelines for health professionals on helping people adhere to their hepatitis C treatment.
A clinical trial is now open for people who have been diagnosed with chronic Hepatitis B Virus (HBV) infection, who have not had treatment for this condition in the last 2 years. Other entry requirements apply.
Early bird registration is now open for the 23rd National Symposium on Hepatitis B and C.
Margot Robbie's "toe mojis" may seem fun but home tattoos - by Hollywood celebs or otherwise - are fraught with risks.
Treasurer Scott Morrison revealed that Government spending on the new hepatitis C drugs led Australia's economic growth in the last quarter.
